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Abstract: Physicians and healthcare networks have been slow to adopt 
electronic medical records and to integrate medical data with the ubiquitous 
mobile device. Mobile and wearable systems for continuous health monitoring 
constitute a key technology in helping the transition of health care to a more 
proactive and affordable healthcare. Cardiovascular Disease (CVD) includes 
dysfunctional conditions of the heart, arteries, and veins that supply oxygen to 
vital life-sustaining areas/organs of the body. CVD singly accounts for about 
40% of all deaths worldwide. Over 80 per cent of CVD deaths take place in 
low- and middle-income countries. An estimated 17.5 million people died from 
cardiovascular disease in 2005, and expected to top 20 million per year by 
2015. By 2030, more than 23 million people will die annually from CVDs. 
CVDs’ patients face risks of recurrent acute cardiovascular events, hospital re-
admission, and unfavourable quality of life. Heart Failure, (HF), leads to death 
if not properly managed and supervised. Current treatments for Congestive 
Heart Failure (CHF) provide a limited palliative outcome. New technologies 
are now pertinent to generate high-dimensional data that provide 
unprecedented opportunities for unbiased identification of biomarkers that can 
be used to optimize pre-operative planning, with the goal of avoiding costly 
post-operative complications and prolonged hospitalization. Due to the crucial 
role of remote monitoring for CVD patients, significant efforts from research 
communities and industry to propose and design a variety of CVD monitoring 
devices have become imperative. This paper builds a proof-of-concept and 
presents a cardiovascular monitoring system, Cardiovascular Disease 
Management System (CVDMS), for real-time information on patient’s heart 
health status with respect to his/her heart beat in hemodynamics computation 
towards reducing re-admission incidence problem. Administered 485 
questionnaires and interviewed 12 cardiologists, 45 physicians, and 23 
pharmacists to gather details on vital CVD parameters. 469 of 485 
questionnaires (96.70%) were validly completed and returned, while 16 
(3.30%) were not. Searched internet databases and cognate texts for literature. 
A mobile CVDMS for HF was developed using UML, MySQL Server 5.0, 
Java servlets, Apache Tomcat 6.0 server, microcontroller, and Ozeki sms 
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server. Patient completes a questionnaire on a J2ME platform-based computing 
device that measures the heartbeat rate. Biological signals acquired by CVDMS 
are processed by microcontroller. Pulses are counted within a space of one 
minute to know heartbeat rate per minute. The CVDMS application gets the 
heartbeat reading, and if the heart rate is abnormal, a trigger is set enabling the 
Ozeki SMS Gateway to send an alert to patient’s next-of-kin and cardiologist. 
CVDMS guarantees individual patient’s direct involvement to closely monitor 
changes in his/her vital signs and provide feedback to maintain an optimal 
health status. Medical personnel get alerted when life-threatening changes 
occur in establishing proper communication between patient and cardiologist 
via sms. Hemodynamics computation could be performed with the parameters 
obtained from the data supplied by CVDMS as a cardiovascular intervention to 
save many lives and improve quality of life.  
              
Keywords: artery stiffness; blood pressure; cardiologist; cardiovascular disease; 
heart attack; heart failure; hemodynamic volumetric parameters; hospital re-
admission; hypertension;  risk-factor. 
 
1. Introduction 
The cardiovascular system consists of 
heart, vessels, and blood. In a healthy 
person, the heart pumps the blood in 
vessels with synchronous pulses (HR) 
and pulse wave velocity (PWV). The 
source of power of life is the heart, and 
the blood nourishing the body 
constantly flows under her impetus. 
However, she also demands the 
nourishing of blood. Coronary artery, 
namely three blood vessels respectively 
located in the heart, can supply blood 
and oxygen to her. The coronary artery 
is the artery special for supplying blood 
to the heart. If cholesterol and other 
substances are accumulated in the blood 
vessels, the vascular cavity will be 
narrower or be blocked and the blood 
flow will be smooth and then be blocked 
to cause cardiac ischemia and a series of 
symptoms which are coronary heart 
disease, namely coronary 
atherosclerosis. Coronary heart disease 
(CHD)  is also called as coronary 
atherosclerotic heart disease. The 
excessive fat deposition results in 
atherosclerosis and weakened elasticity. 
The mortality of human on 
cardiovascular and cerebrovascular 
diseases induced on the arterial vessel 
wall has exceeded 1 / 2 of the total 
mortality of population. Dangerous 
factors making the elasticity of coronary 
artery weakened are high blood fat, 
smoking, diabetes, obesity, high blood 
pressure, lack of physical activity, 
psychological overstrain, family history 
of coronary heart disease, oral 
contraceptive, etc.  The force of blood 
flux, which is caused by heart beating, 
forms a pressure against blood vessels’ 
walls. Blood pressure,  (BP),  is a vital 
measurement used by the physicians for 
diagnosing the health situation of 
subjects, and saving them from critical 
diseases or some dangerous 
circumstances, such as hypertension, 
hypotension, artery stiffness, coma or 
heart attack (Al-Jaafreh and Al-Jumaily, 
2008). Cardiovascular Disease (CVD) 
includes dysfunctional conditions of the 
heart, arteries, and veins that supply 
oxygen to vital life-sustaining areas of 
the body like the brain, the heart itself, 
and other vital organs. Cardiovascular 
disease, including heart disease and 
stroke, remains the leading cause of 
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death around the world. CVD being the 
prime cause of death among the elderly 
in industrialized countries is a major 
determinant of chronic disability. 
Cardiovascular diseases represent the 
main cause of death for people of 
developed countries, and frequently they 
may account for premature fatal 
outcomes even in the apparently healthy 
young. The morbid entities are mostly 
structural, affecting the major 
components of the heart (aorta, 
pulmonary artery, pericardium, coronary 
arteries, myocardium, endocardium and 
conduction system). Yet, most heart 
attacks and strokes could be prevented if 
it were possible to provide an easy and 
reliable method of monitoring and 
diagnostics. In particular, the early 
detection of abnormalities in the 
function of the heart, called arrhythmias, 
could be valuable for clinicians (Nataraj 
et al. 2012; Thiene and  Basso, 2015). 
Bausch-Jurken and  Kotchen (2015) 
asserted that American Heart 
Association (AHA) had estimated the 
total cost, both direct and indirect, of 
cardiovascular disease (CVD) and 
stroke in the United States to be $312.6 
billion. AHA also projected the cost of 
cardiovascular care to increase to an 
estimated $818.1 billion by 2030. AHA 
has attributed 40.6% of CVD to 
hypertension, 13.7% to smoking, 13.2% 
to poor diet, 11.9% to inactivity, and 
8.8% to abnormal blood glucose. Walsh 
et al. 2014 reported physicians and 
healthcare networks have been slow to 
adopt electronic medical records and to 
integrate medical data with the 
ubiquitous mobile device. The need for 
cardiac diagnostics, like 
electrocardiography (ECG) holters or 
cardiac event recorder resulted in 
creation of such devices about 50-years 
ago (Wcislik et al. 2015). In 
cardiovascular prevention, there is 
classically a small number of 
cardiovascular risk factors to treat, such 
as hypertension, diabetes, 
hyperlipidemia and smoking excess, 
which are widely detected and treated. 
Recently, it has been widely recognized 
that new mechanical factors should be 
detected and treated and involves 
specifically pulsatile arterial 
hemodynamic (PAH) parameters such 
as: arterial stiffness, pulse pressure, and, 
to a lesser extent, augmentation index 
and pulse pressure amplification. 
 
Mobile and wearable systems for 
continuous health monitoring are a key 
technology in helping the transition of 
health care to a more proactive and 
affordable healthcare. Wearable health 
monitoring systems allow an individual 
to closely monitor changes in her or his 
vital signs and provide feedback to help 
maintain an optimal health status.  If 
integrated into a telemedical system, 
these systems can even alert medical 
personnel when life-threatening changes 
occur. Patients can benefit from 
continuous long-term monitoring as a 
part of a diagnostic procedure, can 
achieve optimal maintenance of a 
chronic condition, or can be supervised 
during recovery from an acute event or 
surgical procedure (Milenković et al. 
2006).  
 
2. Literature Survey 
Methods of medical diagnosis are 
continuously being improved and 
extended. Ulucam, 2012,  identified the 
most well-known CVD risk factors in 
the elderly as high blood pressure (BP), 
wide pulse pressure, age (male > 55, 
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women > 65), smoking, dyslipidemia 
(total cholesterol >190 mg/dL, or LDL 
cholesterol >115 mg/dL, or HDL 
cholesterol in men <40 mg/dL, female 
<46 mg/dL, triglyceride >150 mg/dL), 
fasting glucose 102-125 mg/dL, 
abnormal glucose tolerance test, 
diabetes mellitus, abdominal obesity 
(abdominal circumference: M > 102 cm, 
F > 88 cm), and a family history of 
premature CVD disease. Unhealthy 
lifestyle behaviours, including smoking, 
physical inactivity, hazardous alcohol 
consumption and low intake of fruit and 
vegetables have been shown to 
contribute to the development of 
coronary heart disease (CHD), which 
remains a leading cause of death 
worldwide (Dale et al. 2014). Kilty and 
Prentice, 2012 and Kong and Choi, 2012 
reported CVDs have become one of the 
leading causes of morbidity and 
premature mortality in men and women 
in the industrialized world and many 
developing countries. The leading 
global risks for mortality in the world 
were high blood pressure (13% of global 
deaths), tobacco use (9%), high blood 
glucose (6%), physical inactivity (6%) 
and overweight or obesity. It was also 
predicted that by the year 2020, CVDs 
would be the leading cause of death in 
the entire world. Heart attacks and CHD 
are primarily caused by atherosclerosis, 
where a narrowing and hardening of the 
arteries result from an accumulation of 
fat and cholesterol deposits called 
plaque. Gaziano et al. 2015 documented 
cardiovascular disease (CVD) to have 
emerged as the single most important 
cause of death worldwide. In 2010, 
CVD caused an estimated 16 million 
deaths and led to 293 million disability-
adjusted life-years (DALYs) lost — 
accounting for approximately 30% of all 
deaths and 11% of all DALYs lost that 
year. Like many high-income countries 
(HICs) during the past century, now 
low- and middle-income countries 
(LMICs) are seeing an alarming and 
accelerating increase in CVD rates.
 Haslam and James, 2005 found 
CVD, with an emphasis on congestive 
heart failure, was being studied using 
proteomics and continues to be 
increasingly relevant to an aging 
population. Recently, NCD has become 
an important cause of mortality & 
morbidity in developing countries. 
Diabetes Mellitus (DM) and 
hypertension are major predisposing 
factors to CVD. Upsurge of DM & 
hypertension is propelled by growing 
prevalence of overweight and obesity 
worldwide, especially among children & 
adolescents.  Heart failure, (HF), a 
condition where the heart is no longer 
able to maintain adequate blood 
circulation, results from myocardial 
dysfunction that impairs the heart's 
ability to circulate blood at a rate 
sufficient to maintain the metabolic 
needs of peripheral tissues and various 
organs. Heart failure is a relatively 
common clinical disorder, estimated to 
affect more than 2 million patients in the 
United States. About 400,000 new 
patients develop congestive heart failure 
(CHF) each year. Morbidity and 
mortality rates are high; annually, 
approximately 900,000 patients require 
hospitalization for CHF, and up to 
200,000 patients die from this condition. 
The average annual mortality rate is 40–
50% in patients with severe (New York 
Heart Association (NYHA) class IV) 
heart failure (Deedwania, 2007). Some 
causes of heart failure include coronary 
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artery disease, valvular disease, and 
myocardial infarction. Heart failure is a 
common disease in the Western world 
with a high prevalence and steadily 
rising incidence. Two major reasons 
contribute to the increasing incidence in 
this part of the world: firstly, better 
treatment of cardiovascular disease, in 
particular of acute ischemic events, such 
as myocardial infarcts which keep more 
people alive, however often at the cost 
of damaged, malfunctioning heart 
muscle, the first step on the road to heart 
failure; and secondly, an ageing 
population – heart failure is typically a 
disease of the elderly. The average age 
of the heart failure patient in the 
community is 74-75 years. Average 
prevalence of heart failure is 2-2.5% 
overall, increasing to >10% in 
octogenarians; up to 14 million 
inhabitants of Europe have heart failure; 
and average incidence of heart failure is 
15/1000 inhabitants in people ≥55 years, 
but increases significantly in the elderly. 
It is now recognized that approximately 
40% of all heart failure patients may 
have a preserved pump function of the 
left chamber (left ventricle- LV) of the 
heart. Patients with HF have a worse 
quality of life than those with almost 
any other chronic disease including 
bronchitis/emphysema, kidney failure 
and arthritis. Chronic diseases are 
common and costly, yet they are also 
among the most preventable health 
problems (WHFS, 2010). 
 
2.1 Therapy and Treatment 
reatment of cardiovascular disorders is 
one of the most highly evidence-based 
area of medicine and pharmacy practice. 
A careful patient history and physical 
examination are extremely important in 
diagnosing cardiovascular disease and 
should be done prior to any test. Heart 
sounds and heart murmurs are important 
in identifying heart valve abnormalities 
and other structural cardiac defects. 
Elevated jugular venous pressure is an 
important sign of heart failure and may 
be used to assess severity and response 
to therapy (Talbert, 2005). Accounting 
for more than 40% of deaths each year, 
cardiovascular disease remains the 
leading cause of mortality in the United 
States. Contributing to this mortality are 
two key conditions: myocardial 
infarction and congestive heart failure. 
Myocardial infarction triggers the 
formation of scar tissue, which is one of 
the causes of congestive heart failure. 
Current treatments for congestive heart 
failure provide a limited palliative 
outcome; therefore, myocardial 
infarction and congestive heart failure 
could benefit substantially from cell 
therapies. Such therapies could benefit 
not only patients but also the healthcare 
system in terms of burden of resources 
and financing (Sage, 2008). 
Improvements in health care and 
treatment of diseases have led to an 
increase in life expectancy in developed 
countries. However, this achievement 
has also inadvertently increased the 
prevalence of chronic illnesses such as 
cardiovascular disease, adding to the 
growing burden of health care cost 
globally. Ironically, the recent 
improvements in treating ischemic 
disease have increased the number of 
patients living with congestive heart 
failure, the fastest-growing segment of 
cardiovascular disease. Unfortunately, 
this prevalence trend is expected to 
escalate in the foreseeable future. 
Cardiovascular disease remains one of 
the main problems in contemporary 
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health care worldwide, accounting for 
approximately one third of the world’s 
total death (Poole-Wilson, 2005). 
Although >80% of global burden of 
CVD occurs in developing countries, 
however, knowledge on the risk factors 
is largely derived from developed 
countries (Parvez, 2007).  Kilty and 
Prentice (2012)’s model of CVD 
treatment as presented in Figure 1  
reports that there is strong evidence that 
cardiovascular risk factors begin and 
can be identified in childhood and 
adolescence that influence the 
development of CVD in adulthood. 
They called for interdisciplinary and 
interprofessional teams of researchers, 
clinicians, educators, parents and care 
providers to work together on this health 
issue and inform each other of their 
outcomes. 
 
 
 
                    Figure 1 Comprehensive Treatment CVD Model (Kilty and Prentice, 2012) 
 
New technologies are pertinent to 
generate high-dimensional data that 
provide unprecedented opportunities for 
unbiased identification of biomarkers 
that can be used to optimize pre-
operative planning, with the goal of 
avoiding costly post-operative 
complications and prolonged 
hospitalization (Aggeli et al; 2014). 
Mobile technologies have been 
confirmed to offer the ability to connect 
patients with their doctors, care-givers 
and loved ones and enable timely health 
monitoring which suggests improved 
patient engagement and better health 
outcomes. Mobile technology provides 
aid in providing access to information, 
helping to lower costs, facilitating 
remote care and increasing efficiencies 
by connecting patients to their providers 
virtually anywhere. Mobile health 
applications and services are becoming 
an essential tool in extending health care 
resources around the world (West, 
2013).  Smart phone apps and wearable 
sensors are promising for improving 
cardiovascular health behaviors, 
preliminary data suggest. Self-
monitoring is a key facet of changing 
behavior to prevent and manage heart 
health. Smartphone apps and wearable 
sensors have the potential to encourage 
positive change (AHA, 2015). Boursalie 
et al 2015 presented M4CVD: a Mobile 
Machine Learning Model for 
Monitoring Cardiovascular Disease, a 
system designed specifically for mobile 
devices that facilitates monitoring of 
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cardiovascular disease (CVD). M4CVD 
using wearable sensors collects 
observable trends of vital signs 
contextualized with data from clinical 
databases. Instead of transferring the 
raw data directly to the health care 
professionals, M4CVD performs 
analysis on the local device by feeding 
the hybrid of collected data to a support 
vector machine (SVM) to monitor 
features extracted from clinical 
databases and wearable sensors to 
classify a patient as ―continued risk‖ or 
―no longer at risk‖ for CVD. These 
statistics suggest that health care needs a 
major shift toward more scalable and 
more affordable solutions including 
measuring the rate of heartbeat using 
mobile computing technologies to 
monitor and ensure proper 
communication between the patient and 
cardiologist addressed in this paper. 
 
2.2 Control of Cardiovascular 
System: Hemodynamic volumetric 
parameters  
Hemodynamics has been defined as the 
study of the relationship among physical 
factors affecting blood flow through the 
vessels. Blood flow is a function of 
pressure difference and resistance. 
Blood flow (F) through a blood vessel is 
determined by two main factors: (1) 
pressure difference (ΔP) between the 
two ends of the vessel and (2) the 
resistance (R) to blood flow through the 
vessel (Figure 2). 
 
 
 
                
                       Figure 2 Blood flow through a blood vessel (Nasimi, 2012) 
 
The equation relating these parameters 
is: 
F = ΔP/R    (1) 
This equation is called Darcy’s law or 
Ohm’s law. 
 
Flow (F) is defined as the volume of 
blood passing each point of the vessel in 
one unit time. Usually, blood flow is 
expressed in milliliters per minute or 
liters per minute, but it is also expressed 
in milliliters per second. Pressure which 
is the force that pushes the blood 
through the vessel is defined as the force 
exerted on a unit surface of the wall of 
the tube perpendicular to flow.  
 
Pressure is expressed as millimeters of 
mercury (mmHg). Since the pressure is 
changing over the course of the blood 
vessel, there is no single pressure to use; 
therefore the pressure parameter used is 
pressure difference (ΔP), also called 
pressure gradient, which is the 
difference between the pressure at the 
beginning of the vessel (P1) and the 
pressure at the end of the vessel (P2), 
i.e. ΔP = P1 - P2. As seen in the Darcy’s 
law, ΔP is the cause of the flow; with no 
pressure difference there would be no 
flow. The pressure energy is produced 
by the ventricle and it drops throughout 
the vessel due to resistance. In other 
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words, resistance is the cause of the 
pressure drop over the course of a 
vessel. Resistance is how difficult it is 
for blood to flow from point 1 to point 
2. Resistance impedes flow and it is a 
measure of interactions between flowing 
particles (including molecules and ions) 
themselves and interactions between 
flowing particles and the wall of the 
vessel.  
 
As seen Darcy’s law, resistance is the 
impeding cause of the flow; the bigger 
the resistance the lesser the flow. If the 
resistance is Δ (complete closure of the 
vessel) there will be no flow. 
The resistance equation is: 
R = 8ηL / πr4     (2) 
where η = fluid viscosity 
L = vessel length 
r = inside radius of the vessel. 
Viscosity represents the interactions 
between flowing particles themselves 
and radius represents the interactions 
between flowing particles and the wall 
of the vessel. The units of viscosity are 
Pa⋅s = Ns/m2, or Poise (dynes⋅s/cm2), 
with 1 Pa⋅s = 10 Poise (Nasimi, 2012). 
 
Rudenko et al. 2012 has asserted the 
foundation of hemodynamics as the 
phase mode of the heart performance 
such that in one beat, the heart changes 
its shape ten times that corresponds to 
the heart cycle phases. The most 
efficient way is to evaluate the status of 
hemodynamics not only by values of 
integral parameters, i.e., stroke and 
minute volumes, but also phase-related 
volumes of blood entering or leaving the 
heart in the respective phase in a cardiac 
cycle. The final formulae for calculating 
the volumes of blood in the phase of 
rapid and slow ejection, symbolized as 
PV3 and PV4, respectively, are as 
follows: 
PV3=S•(QR+RS)2 • f1(α ) • (f2(α )+f3(α 
,β ,γ ,δ ) (ml); (1) 
PV4=S• (QR+RS)2• f1(α )• f4(α ,β ,γ ,δ ) 
(ml),       (2) 
where S - cross-section of ascending 
aorta; 
QR – phase duration according to ECG 
curve; 
RS – phase duration according to ECG 
curve; 
f1(α )= 22072.5((5α - 2)
3
 -  27) / ((5α - 
2)
5
 – 243); 
 
f2(α)=  (α
5
 – 1)/2; 
 
f3(α ,β ,γ ,δ )= 
1
8
(
10
3
(4α2 −δ2 )(β3 −α3) 
+5 χδ(β4 −α4) − 2χ2(β5 −α5); 
            
f4(α ,β ,γ ,δ )= 
1
8
(
5
3
(δ2 − 8α2) (β3 −α3) + 
7.5χδ(β4 −α4) + 3χ2(β5 −α5); 
           
α =  (1+ Em )0.2 ; 
            QR+ RS 
 
β =  (1+ Em+ Er )0.2 ; 
            QR+ RS 
 
χ  = 2(α− 1) / (β – α); 
  
δ =α(2 +χ ). 
 
Stroke volume, SV, is calculated by an 
equation as given below: 
SV = PV3+ PV4=S• (QR+RS)2• f1(α)• 
(f2(α) + f3(α,β,γ,δ )+f4(α ,β ,γ ,δ )) (ml) 
            (3) 
The minute stroke is computed as 
follows: 
МV = SV• HR (l/min)      (4) 
In similar way calculated are other 
phase-related volumes of blood as listed 
below: 
PV1 – volume of blood entering the 
ventricle in premature diastole; 
PV2 – volume of blood entering the 
ventricle in atrial systole; 
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PV5 – volume of blood pumped by 
ascending aorta as peristaltic pump. 
 
So, the main parameters in 
hemodynamics are 7 volumes of blood 
entering or leaving  the heart in different 
heart cycle phases. They are as follows: 
stroke volume SV, minute volume MV, 
two diastolic phase-related volumes 
PV1 and PV2, two systolic phase-
related volumes PV3 and PV4, and PV5 
as volume of blood pumped by the 
aorta. These hemodynamic parameters 
should be used mainly in order to 
evaluate eventual deviations from their 
normal values, if any. The limits of 
normal values of hemodynamic 
parameters are not conditional, and they 
have their respective calculated values. 
With respect to the normal values (the 
required parameters) in hemodynamics, 
they have been taken on the basis of the 
known data on ECG waves, intervals 
and segments for adults from the 
literature sources as given below: 
1.  The upper and lower limit of the 
QRS complex values: 
QRSmax = 0.1 s; 
QRSmin = 0.08 s. 
2. The upper and lower limit of the RS 
complex values: 
RSmax = 0.05 s;      
RSmin = 0.035 s. 
3. The normal value of interval QT in 
every specific cardiac cycle is 
determined from the Bazett formula as 
follows: 
QT = 0.37  RR0.5 s (for men);                                           
QT = 0.4    RR0.5 s (for women).                                         
4. Normal value PQ is calculated from a 
formula as indicated below: 
PQ = 1 / (10
-6
   638, 44  HR
2
 + 9,0787) 
s.       
This equation has been produced 
according to the method of 
approximation of normal values PQ, as 
known from the sources, considering 
their dependence on heart rate (HR) 
(Rudenko et al. 2012). 
 
Hemodynamic instability is most 
commonly associated with abnormal or 
unstable blood pressure (BP), especially 
hypotension, or more broadly associated 
with inadequate global or regional 
perfusion. Inadequate perfusion may 
compromise important organs, such as 
heart and brain, due to limits on 
coronary and cerebral auto regulation 
and cause life-threatening illnesses, or 
even death. Therefore, it is crucial to 
identify patients who are likely to 
become hemodynamically unstable to 
enable early detection and treatment of 
these life-threatening conditions (Cao et 
al. 2008). Modern intensive care units 
(ICU) employ continuous hemodynamic 
monitoring (e.g., heart rate (HR) and 
invasive arterial BP measurements) to 
track the state of health of the patients. 
However, clinicians in a busy ICU 
would be too overwhelmed with the 
effort required to assimilate and 
interpret the tremendous volumes of 
data in order to arrive at working 
hypotheses. Consequently, it is 
important to seek to have automated 
algorithms that can accurately process 
and classify the large amount of data 
gathered and to identify patients who are 
on the verge of becoming unstable (Cao 
et al. 2008). Modern ICUs are equipped 
with a large array of alarmed monitors 
and devices which are used to try to 
detect clinical changes at the earliest 
possible moment so as to prevent any 
further deterioration in a patient’s 
condition. The effectiveness of these 
systems depends on the sensitivity and 
specificity of the alarms, as well as on 
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the response of the ICU staff to the 
alarms. However, when large numbers 
of alarms are either technically false, or 
true, but clinically irrelevant, response 
efficiency can be decreased, reducing 
the quality of patient care and increased 
patient (and family) anxiety (Nataraj et 
al. 2012). 
 
3. Statement of the Problem 
Heart Failure (HF) is a leading cause of 
hospitalization for people 65 years of 
age and older, and rates of hospital 
readmission within 6 months range from 
25% to 50%. HF is managed by patients 
suffering from it visiting the doctor 
regularly for check up and treatment. 
Patients are not fully involved in some 
vital tasks, which if they could do for 
themselves would ease the doctors of 
some work.  
 
4. Methods 
We administered 485 questionnaires and 
interviewed 12 cardiologists, 45 
physicians, and 23 pharmacists. 
Pertinent questions during the data 
collection phases centred on 
cardiovascular parameters including 
Blood Viscosity, Cholesterol Crystal, 
Blood Fat, Vascular Resistance, 
Vascular Elasticity, Myocardial Blood 
Demand, Myocardial Blood Perfusion 
Volume, Myocardial Oxygen 
Consumption, Stroke Volume, Left 
Ventricular Ejection Impedance, Left 
Ventricular Ejection Impedance, Left 
Ventricular Effective Pump Power, 
Coronary Artery Elasticity, Coronary 
Perfusion Pressure, Cerebral Blood 
Vessel Elasticity, and Brain Tissue 
Blood Supply Status. Cognate registries 
including Cardiac Arrest Registry to 
Enhance Survival (CARES), the 
Cardiovascular Research Network 
(CVRN), the National Cardiovascular 
Data Registry (NCDR), the International 
Registry of Aortic Dissection (IRAD), 
and the Global Registry for Acute 
Cardiac Events (GRACE) were 
consulted to collect information on 
cardiovascular disease. Literature 
databases such as MEDLINE, APAIS, 
Google Scholar and the Clinicians 
Health Channel were searched. Search 
terms used included ―cardiovascular*‖, 
―mortality*‖, ―cardiac‖, ―heart*‖, 
―blood*‖, ―non-communicable*‖, 
―hyperten*‖, ―myocardial*‖, and ―risk 
factor‖.  
 
As guided by international standards of 
the Institute of Medicine (IOM), 
detailed information on chronic 
conditions—including cardiovascular 
disease, diabetes, and respiratory health 
and disease—were collected by the 
administered questionnaire, and 
participants were assisted to undergo 
comprehensive dietary interviews and 
body measurements. The cardiologists, 
by standard practice, undertook physical 
examination that included several 
measures relevant to CVD and 
respiratory diseases, including blood 
pressure and spirometry, as well as 
cardiovascular fitness, body mass index, 
and body composition. Relevant 
biomarkers include cholesterol and 
triglyceride measures, C-reactive 
protein, and fasting plasma glucose. In 
addition to interviews with cardiologists 
to gather cognate questions, this project 
employed Unified Modeling Language 
(UML)’s use case, sequence, 
collaboration diagrams to formalize the 
functional requirements / interaction 
between a patient and a cardiologist as 
shown in Figure 3. 
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               Figure 3 System Class Diagram of the CVDMS 
 
 
The resulting framework was 
implemented on Edition Java 2 Platform 
(J2ME), MySQL Server 5.0, Java 
servlets, Apache Tomcat 6.0 server, and 
Ozeki sms server for emergency sms. 
Cardiovascular Diseases Management 
System (CVDMS) has modules 
designed for the patient’s end to aid 
proper monitoring by the cardiologist 
and proper communication with the 
cardiologist. 
5. Results 
469 of 485 questionnaires (96.70%) 
were validly completed and returned, 
while 16 (3.30%) were not.  
Cardiovascular parameters normal range 
values (lower bound, median, and upper 
bound) confirmed from cardiologists are 
as presented in Figure 4. 
 
   58 
OMOGBADEGUN Z. O. & ADEGOKE A. T.                                                          CJICT (2016) 4(2) 48-70                    
 
                       
 
 
 
 
                      Figure 4 Cardiovascular Parameters Normal Range Values 
 
 
Cardiologists confirmed, among other 
pertinent things, that Myocardial 
Oxygen Consumption (the milliliter 
value of oxygen consumption of heart 
per minute) is influenced by: (1) Heart 
rate: the heart rate is fast, and the HOV 
is great; (2) Myocardial contractility: the 
cardiac contractility is strong, and the 
HOV is great; and (3) Myocardial 
contraction time: the longer the 
contraction time is, the greater the HOV 
is. Thus, low oxygen consumption and 
high cardiac work are the best state. 
High blood pressure patients with high 
viscosity are prone to have 
cerebrovascular accidents, such as 
stroke and other phenomena; coronary 
heart disease patients with high 
viscosity are prone to have myocardial 
infarction and so on. Increase is in direct 
proportion to the length of blood 
vessels, and is in inverse proportion to 
the caliber of blood vessels. The 
increase of vascular resistance is seen in 
mildly elevated systolic and diastolic 
blood pressure, mild hypertension, 
insomnia with deficiency of heart and 
spleen, phlegm-heat internal confusion 
type insomnia, etc. Decline is seen in 
mildly declined systolic and diastolic 
blood pressure, mild hypotension, Yin 
deficiency and Huo exuberance type 
insomnia, etc. In a case of a 59year-old 
male, 85kg and 175cm height, the 
measurements collected were as shown 
in Figures 5, 6, and 7 to determine the 
risk level (severe partial fat). 
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 Figure 5 Cardiovascular Parameters actual measurements for a 59-yr-old, 175cm, 80kg 
male 
 
 
Figure 6 Pie Chart of Cardiovascular Parameters actual measurements for a 59-yr-old, 
175cm, 80kg male 
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Figure 7 cardiovascular and Cerebrovascular Analysis Report Card 
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We also gathered from the cardiologists 
that stroke volume (the blood volume 
output by the heart in beat each time) 
are equally influenced by:  (1) The 
effective circulating blood volume 
(BV): when the blood volume is 
insufficient, the returned blood volume 
is little, and the SV is reduced; (2) The 
weakening of myocardial contractility: 
the contractility is low, and the pressure 
is low, so the ejected blood volume is 
less; (3) The extent of ventricular filling: 
In range of myocardial elasticity, the 
greater the degree of filling is, the 
stronger the retraction is, and the SV is 
increased. The normal heart chamber 
capacity is 173ml, but not all of the 
blood is ejected. The blood volume in 
the left ventricle is about 60% -70% of 
the total capacity, being about 125ml or 
so; (4) The size of peripheral vascular 
resistance (PR). The PR is large, and 
then the SV is reduced; the PR is small, 
and then the SV is increased; and (5) 
Ventricle wall movement. When the 
ventricle is contracted, the cardiac 
muscle is in coordinated movement. If 
the myocardial contraction is not 
coordinated, the SV is reduced. For 
instance, some patients with myocardial 
infarction have part of infarction, so the 
myocardial contractility is inconsistent 
and the SV is reduced. However, under 
normal circumstances, the ventricle wall 
movement can not be abnormal. 
 
Figure 8 presents the login module for 
proper authentication of the user of this 
application, precisely the patient. The 
patient is given a list of options 
specifying the various functions that can 
be performed by the application on the 
patient’s end. 
 
 
                        Figure 8 Login Menu module 
 
As part of the cardiologist’s monitoring 
exercise, he needs to have a daily report 
on the patient’s health. As such, this 
module enables the patient fill a 
questionnaire daily as shown in Figure 9 
in order to keep the cardiologist abreast 
of the patient’s health status. The 
questions to be filled are basic general 
questions that help doctors in 
determining the general state of the 
patient’s heart. 
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                          Figure 9 Daily Questionnaire & its Filling 
 
After filling the questionnaire, a confirmation screen is displayed  as shown in 
Figure10. 
 
 
 
                     Figure 10 Screenshot showing the confirmation screen 
  
Figure 11 provides help for the patient to send and receive vital messages to and from 
the cardiologist. This is also needed for proper monitoring of a patient and as such 
management of the cardiovascular disease. 
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                          Figure 11 New Message screen / Messaging Option 
 
A patient can view his message inbox 
(messages sent by the doctor to the 
patient), his message outbox (messages 
sent from the patient to the cardiologist). 
The CVDMS also provides an avenue 
for sending messages pertaining to 
health issues to the cardiologist.  
 
The Take Measurement Module 
incorporates the Bluetooth technology to 
receive the rate of the patient’s heartbeat 
from the CVDMS heart monitoring 
device  as shown in Figure 12.  
The device which acts as a slave finds 
the mobile phone and the service it 
offers, then sends the data to the mobile 
phone which acts as the master. The 
Java Bluetooth API plays an important 
role here as it enables better and easy 
communication between both Bluetooth 
devices. 
 
 
 
                Figure 12 Screenshot of the introduction to commence heartbeat reading 
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After taking the measurement, a java 
servlet is called to determine if the heart 
rate is within the normal range. If not, a 
message is stored in the 
ozekimessageout table and tagged as 
―send‖. This means that the message is 
pending. The Ozeki SMS Gateway is 
configured to check the 
ozekimessageout table every 5 seconds 
to check for pending messages. In case 
of pending messages, the server sends 
an emergency sms to the phone of the 
next of kin, the cardiologist and the 
hospital. This will ensure proper 
monitoring and management of the 
cardiovascular disease. The patient can 
view the biodata of both himself and his 
cardiologist’s  as shown in Figure 13. 
 
 
                     Figure 13 Screen shots of Cardiologist's & Patient's Biodata 
 
 
 
5.1 The CVDMS Monitoring Device 
In order to take proper reading and 
measurement of the heartbeat, a 
microcontroller was used for processing 
and an output device called the Liquid 
Crystal Display(LCD) was used to 
display the heartbeat rate. The signals 
sent to the green LED, an indicator for 
the heartbeat, was sent to an STC 8051 
microcontroller and the pulses were 
counted within a space of one minute so 
as to know the rate of heartbeat per 
minute. After determining the rate, the 
value is then displayed on the LCD. 
This was first simulated using the ISIS 7 
Professional and the result’s screenshot 
is shown in Figure 14. 
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Figure 14 Simulation of microcontroller interfaced with LCD (CVDMS heart monitor) 
 
When the mobile application gets the 
heartbeat reading using its Bluetooth 
technology, if the heart rate is abnormal, 
a trigger is set to enable the Ozeki SMS 
Gateway send an alert to the patient’s 
next of kin and cardiologist. The 
obtained values could be substituted in 
Rudenko et al. 2012’s equations to assist 
the cardiologist in his decision-making. 
 
6. Conclusion and future work 
Chronic diseases have been adjudged as 
a costly part of  current healthcare 
delivery system as nearly three-quarters 
of medical expenditures have been 
recorded to have taken place on a small 
number of chronic illnesses, including 
cardiovascular disease, cancer, diabetes, 
and asthma. Heart failure is the cause of 
a high rate of readmission and it 
ultimately leads to death if not properly 
managed and supervised, thereby 
making cardiovascular disease remain 
one of the main problems in 
contemporary health care worldwide, 
accounting for approximately one third 
of the world’s total death. The growing 
incidence of diabetes mellitus and the 
continuing epidemic of cardiovascular 
disease associated with this ailment 
have induced numerous investigators to 
seek evidence of pre-clinical disease 
besides trying to diagnose advanced 
stages of disease. Using a novel 
smartphone adapter, patients are now 
able to capture and transmit single-lead 
ECG data to their healthcare providers. 
Consequently, remote patient 
monitoring has increasingly become an 
attractive solution for the management 
of CVD. This paper, through mobile 
computing technologies, has succeeded 
in achieving acquisition of biological 
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signals (heartbeat) and make them 
available wirelessly over Bluetooth. 
This allows an individual patient’s 
direct involvement to closely monitor 
changes in her or his vital signs and 
provide feedback to help maintain an 
optimal health status. Patients and care 
providers can both benefit from remote 
monitoring as it helps patients be more 
engaged in their health through self-
reported outcomes and provides support 
for cost-effective care.  It also alerts 
medical personnel when life-threatening 
changes occur thereby ensuring proper 
communication between the patient and 
cardiologist via messaging towards 
reducing incidence of re-admission. An 
accurate assessment of BP levels and 
early identification and treatment of 
hypertension is thus essential for 
reducing the cardiovascular risk 
associated with this condition. The use 
of mobile systems that monitor patient 
symptoms and provide real-time advice 
on treatment and medication because 
they have the potential to control costs, 
reduce errors, and improve patients’ 
experiences should be encouraged. The 
Cardiovascular Disease Management 
System (CVDMS), will be evaluated by 
its accuracy in classifying live 
monitored data. We will continue to 
explore methods to test the system’s 
sensitivity to changing patient 
conditions towards the system’s 
improvement following ubiquity of 
technology.
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Appendix  
List of abbreviations used in this manuscript: 
BP Blood Pressure 
CAD  Coronary artery disease  
CBC  Complete Blood Count 
CHD Coronary Heart Disease 
CHF CONGESTIVE HEART FAILURE  
CVA  Cerebrovascular accident  
CVD Cardiovascular Disease 
DM  Diabetes Mellitus  
HF Heart Failure 
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HTML  HyperText Markup Language 
MDG Millennium Development Goal 
MI  Myocardial infarction  
MySQL Microsoft Structured Query Language 
NCD Non-Communicable Disease 
NYHA  New York Heart Association 
PHP  Hypertext Processor Processing Language 
PWV  Pulse Wave Velocity 
UML  Unified Modelling Language 
WHO World Health Organization 
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